Search | IOVS | ARVO Journals

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2011

Rapid Killing Of Contemporary Ocular Staphylococcus Epidermidis (se) And Methicillin Resistant Staphylococcus Aureus (mrsa) Isolates By Clinically Relevant Zymaxid Drug Concentrations

Joseph M. Blondeau; Shantelle D. Borsos; Leah D. Blondeau; Brandon J. Blondeau

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1501. doi:

ARVO Annual Meeting Abstract April 2009

Rate of Methicillin-Resistant Staphylococcus aureus (MRSA) Eradication by Fourth-Generation Fluoroquinolones at Physiologically Relevant Concentrations

J. M. Blondeau; S. D. Borsos; C. Hesje

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5944. doi:

ARVO Annual Meeting Abstract May 2008

Comparative in vitro Potency of Levofloxacin (Lfx) and Gatifloxacin (Gfx) Plus Benzalkonium Chloride (BAK) Against Gram-Positive (GP) Pathogens Including Methicillin-Resistant Staphylococcus aureus (MRSA)

S. D. Borsos; J. M. Blondeau; C. K. Hesje

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1980. doi:

ARVO Annual Meeting Abstract May 2007

Additive Effect of Gatifloxacin and Benzalkonium Chloride (BAK) Against Clinical Isolates of Methicillin-Resistant Staphylococcus Aureus (MRSA)

J. M. Blondeau; S. Borsos; C. Hesje

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):748. doi:

ARVO Annual Meeting Abstract May 2006

Antimicrobial Efficacy of Gatifloxacin With and Without Benzalkonium Chloride Compared With Moxifloxacin Against Methicillin–Resistant Staphylococcus Aureus

J.M. Blondeau; S. Borsos

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1903. doi:

ARVO Annual Meeting Abstract May 2006

Antimicrobial Efficacy of Gatifloxacin With and Without Benzalkonium Chloride Compared With Moxifloxacin Against Common Ocular Pathogens

S.D. Borsos; J.M. Blondeau

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1892. doi:

ARVO Annual Meeting Abstract May 2005

The Antimicrobial Activity of Gatifloxcin (GAT) With or Without Benzalkonium Chloride (BAK) Against Ocular Bacterial Pathogens

J.M. Blondeau; P. Hedlin; S.D. Borsos

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4880. doi:

Advertisement